Today's Daily Dose brings you news about the anticipated clinical trial catalysts of Anavex Life, Histogen, and Lyra Therapeutics; disappointing migraine trial results of Satsuma, and the upcoming regulatory catalyst of Sol-Gel.
from RTT - Biotech https://ift.tt/3hlsKiu
via IFTTT
No comments:
Post a Comment